NCT03183817

Brief Summary

The goal of the research project PROTECT is to translate the Person-Centred Care (PCC) principles into an eHealth (the use of information and communication technologies for health) context. A developed PCC eHealth platform will be used as a tool to identify patients´ resources to enhance coping and living with their chronic illness by means of a dialog and partnership with staff and relatives. The PCC eHealth platform will not replace, but instead be used as add on treatment to usual care (guideline directed care).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
224

participants targeted

Target at P50-P75 for not_applicable heart-failure

Timeline
Completed

Started Aug 2017

Typical duration for not_applicable heart-failure

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 7, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 12, 2017

Completed
2 months until next milestone

Study Start

First participant enrolled

August 17, 2017

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 12, 2020

Completed
1.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2021

Completed
Last Updated

February 25, 2020

Status Verified

February 1, 2020

Enrollment Period

2.5 years

First QC Date

June 7, 2017

Last Update Submit

February 24, 2020

Conditions

Keywords

Person-centred care

Outcome Measures

Primary Outcomes (1)

  • Composite score of changes in general self-efficacy

    The primary efficacy endpoint is a composite score of changes in general self-efficacy 18 based on the General Self-Efficacy Scale (GSE), hospitalization and death. The rationale for such an endpoint is the value of combining patient experience and clinical outcomes. A patient is classified as improved, deteriorated or unchanged: * A patient is classified as deteriorated if any of the following occurred: · at 6 months, self-efficacy has decreased by \> 5 units (the minimal change of clinical significance) or has been admitted to hospital for unscheduled reasons or died. * A patient is classified as improved if: * self-efficacy has increased by \> 5 units and has not been hospitalized. Those who have neither deteriorated nor improved are considered unchanged.

    baseline, 3, 6, 12, 24 months

Secondary Outcomes (9)

  • Number of admissions

    3, 6, 12, 24 months

  • General self-efficacy scale

    3,6,12,24 months

  • Health care utilization

    3,6,12,24 months

  • Incremental cost-utility ratios

    3,6,12, 24 months

  • Health-related quality of life (EQ-5D)

    3,6,12,24 months

  • +4 more secondary outcomes

Study Arms (2)

Person-centred care at distance

EXPERIMENTAL

Person-centred care at distance through an eHealth platform, used both by professionals, patients and relatives

Behavioral: Person-centred care at distance

Usual Care

NO INTERVENTION

Evidence-based care

Interventions

Person-centred care at distance through an eHealth platform

Person-centred care at distance

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • National registration within the Västra Götaland Region (VGR)
  • Men and women listed at a primary care centre in Närhälsan with a history of confirmed diagnosis of COPD and /or CHF
  • Must understand written and spoken Swedish

You may not qualify if:

  • Severe impairment that prevents patient from using the eHealth support
  • No registered address
  • Any severe disease with an expected survival \< 12 months
  • Cognitive impairment (SPMSQ score \>6)
  • Ongoing documented diagnosis of alcohol or drug abuse
  • Other disease that can interfere with follow-up (e.g. severe depression, other severe mental illness)
  • Patient participating in another conflicting randomized study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Primary health care

Gothenburg, Sweden

Location

Related Publications (5)

  • Barenfeld E, Ekman I, Cederberg M, Fors A, Ali L, Gyllensten H. Patient and healthcare professional engagement and time use within a randomised controlled trial: investigating intervention costs associated with remote person-centred care in Sweden. BMJ Open. 2025 Oct 9;15(10):e099034. doi: 10.1136/bmjopen-2025-099034.

  • Harvey BP, Barenfeld E, Fors A, Ekman I, Swedberg K, Gyllensten H. Economic evaluation of a person-centred care intervention with a digital platform and structured telephone support for people with chronic heart failure and/or chronic obstructive pulmonary disease: results from a randomised controlled trial in Sweden. BMJ Open. 2025 Oct 9;15(10):e093083. doi: 10.1136/bmjopen-2024-093083.

  • Ali L, Wallstrom S, Fors A, Barenfeld E, Fredholm E, Fu M, Goudarzi M, Gyllensten H, Lindstrom Kjellberg I, Swedberg K, Vanfleteren LEGW, Ekman I. Effects of Person-Centered Care Using a Digital Platform and Structured Telephone Support for People With Chronic Obstructive Pulmonary Disease and Chronic Heart Failure: Randomized Controlled Trial. J Med Internet Res. 2021 Dec 13;23(12):e26794. doi: 10.2196/26794.

  • Poot CC, Meijer E, Kruis AL, Smidt N, Chavannes NH, Honkoop PJ. Integrated disease management interventions for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2021 Sep 8;9(9):CD009437. doi: 10.1002/14651858.CD009437.pub3.

  • Ali L, Wallstrom S, Barenfeld E, Fors A, Fredholm E, Gyllensten H, Swedberg K, Ekman I. Person-centred care by a combined digital platform and structured telephone support for people with chronic obstructive pulmonary disease and/or chronic heart failure: study protocol for the PROTECT randomised controlled trial. BMJ Open. 2020 Jul 19;10(7):e036356. doi: 10.1136/bmjopen-2019-036356.

MeSH Terms

Conditions

Heart FailurePulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Inger Ekman, Professor

    Institute of health and care sciences, Centre for person-centred care (GPCC)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 7, 2017

First Posted

June 12, 2017

Study Start

August 17, 2017

Primary Completion

February 12, 2020

Study Completion

June 30, 2021

Last Updated

February 25, 2020

Record last verified: 2020-02

Data Sharing

IPD Sharing
Will not share

Locations